Abstract
The prognosis of patients following surgery for gastric cancer is often poor and is estimated using traditional clinicopathological parameters, which can be inaccurate predictors of future survival. Kallikreins are a group of serine proteases, which are differentially expressed in many human tumors and are being investigated as potential cancer biomarkers. This study assessed the prognostic utility of human tissue kallikrein-like peptidases 6 and 10 (KLK6 and KLK10) and correlated their expression with histopathological and clinical parameters in gastric cancer. We constructed a gastric tumor tissue microarray from 113 gastrectomy specimens and quantified KLK6 and KLK10 expression using immunohistochemistry. To overcome the problem of inter-observer variability and subjectivity in immunohistochemistry interpretation, a whole-slide scanned image of the tissue microarray was analyzed using an automated algorithm to quantify staining intensity. KLK6 expression was positively correlated with nodal involvement (p=0.002) and was predictive of advanced-stage disease (p<0.05). Kaplan-Meier survival curves revealed that tumors expressing high levels of KLK6 were significantly associated with significantly lower overall survival (p=0.04). KLK10 overexpression was also a predictor of advanced-stage disease (p<0.01), but was not significantly correlated with lymph node involvement or survival period. Our results show the potential ability of KLK6 as a prognostic marker for gastric cancer.
Acknowledgments
This work was supported by grants from the Canadian Institute of Health Research, Kidney Foundation of Canada, the Kidney Cancer Research Network of Canada, and Prostate Cancer Canada.
References
Bayés, A., Tsetsenis, T., Ventura, S., Vendrell, J., Aviles, F.X., and Sotiropoulou, G. (2004). Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biol. Chem. 385, 517–524.10.1515/BC.2004.061Search in Google Scholar PubMed
Borgoño, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876–890.10.1038/nrc1474Search in Google Scholar PubMed
Drucker, K.L., Paulsen, A.R., Giannini, C., Decker, P.A., Blaber, S.I., Blaber, M., Uhm, J.H., O’Neill, B.P., Jenkins, R.B., and Scarisbrick, I.A. (2013). Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma. Neuro. Oncol. 15, 305–318.10.1093/neuonc/nos313Search in Google Scholar PubMed PubMed Central
Feng, B., Xu, W.-B., Zheng, M.-H., Ma, J.-J., Cai, Q., Zhang, Y., Ji, J., Lu, A.-G., Qu, Y., Li, J.-W., et al. (2006). Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. J. Gastroenterol. Hepatol. 21, 1596–1603.10.1111/j.1440-1746.2006.04228.xSearch in Google Scholar PubMed
Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C., and Parkin, D.M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917.10.1002/ijc.25516Search in Google Scholar PubMed
Ghosh, M.C., Grass, L., Soosaipillai, A., Sotiropoulou, G., and Diamandis, E.P. (2004). Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193–199.10.1159/000081102Search in Google Scholar PubMed
Huang, W., Zhong, J., Wu, L.-Y., Yu, L.-F., Tian, X.-L., Zhang, Y.-F., and Li, B. (2007). Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer. Cancer Lett. 251, 78–85.10.1016/j.canlet.2006.11.006Search in Google Scholar PubMed
Huang, W., Tian, X.-L., Wu, Y.-L., Zhong, J., Yu, L.-F., Hu, S.-P., and Li, B. (2008). Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene. World J. Gastroenterol. 14, 5810–5815.10.3748/wjg.14.5810Search in Google Scholar PubMed PubMed Central
Kamangar, F., Dawsey, S.M., Blaser, M.J., Perez-Perez, G.I., Pietinen, P., Newschaffer, C.J., Abnet, C.C., Albanes, D., Virtamo, J., and Taylor, P.R. (2006). Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J. Natl. Cancer Inst. 98, 1445–1452.10.1093/jnci/djj393Search in Google Scholar PubMed
Kim, J.J., Kim, J.-T., Yoon, H.R., Kang, M.A., Kim, J.H., Lee, Y.-H., Kim, J.W., Lee, S.-J., Song, E.Y., Myung, P.K., et al. (2012). Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer. Tumour Biol. 33, 731–738.10.1007/s13277-011-0267-1Search in Google Scholar PubMed
Lei, K.-F., Liu, B.-Y., Zhang, X.-Q., Jin, X.-L., Guo, Y., Ye, M., and Zhu, Z.-G. (2012). Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors. Exp. Ther. Med. 3, 109–116.10.3892/etm.2011.353Search in Google Scholar PubMed PubMed Central
Li, M., Zhao, Z.W., Zhang, Y., and Xin, Y. (2011). Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer. Dig. Dis. Sci. 56, 698–706.10.1007/s10620-010-1346-7Search in Google Scholar PubMed
Linder, N., Konsti, J., Turkki, R., Rahtu, E., Lundin, M., Nordling, S., Haglund, C., Ahonen, T., Pietikäinen, M., and Lundin, J. (2012). Identification of tumor epithelium and stroma in tissue microarrays using texture analysis. Diagn. Pathol. 7, 22.10.1186/1746-1596-7-22Search in Google Scholar PubMed PubMed Central
Liu, X.L., Wazer, D.E., Watanabe, K., and Band, V. (1996). Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56, 3371–9.Search in Google Scholar
Liu, X., Xiong, H., Li, J., He, Y., and Yuan, X. (2013). Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer. Diagn. Pathol. 8, 62.10.1186/1746-1596-8-62Search in Google Scholar PubMed PubMed Central
Nagahara, H., Mimori, K., Utsunomiya, T., Barnard, G.F., Ohira, M., Hirakawa, K., and Mori, M. (2005). Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin. Cancer Res. 11, 6800–6806.10.1158/1078-0432.CCR-05-0943Search in Google Scholar PubMed
Pasic, M.D., Olkhov, E., Bapat, B., and Yousef, G.M. (2012). Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. Biol. Chem. 393, 319–330.10.1515/hsz-2011-0273Search in Google Scholar PubMed
Pasic, M.D., Samaan, S., and Yousef, G.M. (2013). Genomic medicine: new frontiers and new challenges. Clin. Chem. 59, 158–67.10.1373/clinchem.2012.184622Search in Google Scholar PubMed
Petraki, C.D., Karavana, V.N., Skoufogiannis, P.T., Little, S.P., Howarth, D.J., Yousef, G.M., and Diamandis, E.P. (2001). The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J. Histochem. Cytochem. 49, 1431–1441.10.1177/002215540104901111Search in Google Scholar PubMed
Petraki, C., Dubinski, W., Scorilas, A., Saleh, C., Pasic, M.D., Komborozos, V., Khalil, B., Gabril, M.Y., Streutker, C., Diamandis, E.P., et al. (2012). Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Pathol. Res. Pract. 208, 104–108.10.1016/j.prp.2011.12.010Search in Google Scholar PubMed
Ruifrok, A.C. and Johnston, D.A. (2001). Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 23, 291–299.Search in Google Scholar
Scorilas, A. and Mavridis, K. (2012). Kallikrein-related peptidases (KLKs) as novel potential biomarkers in gastric cancer: an open yet challenging road lies ahead. J. Surg. Oncol. 105, 223–224.10.1002/jso.22041Search in Google Scholar PubMed
Shah, M.A. and Ajani, J.A. (2010). Gastric cancer – an enigmatic and heterogeneous disease. J. Am. Med. Assoc. 303, 1753–1754.10.1001/jama.2010.553Search in Google Scholar
Varga, Z., Diebold, J., Dommann-Scherrer, C., Frick, H., Kaup, D., Noske, A., Obermann, E., Ohlschlegel, C., Padberg, B., Rakozy, C., et al. (2012). How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS One 7, e37379.10.1371/journal.pone.0037379Search in Google Scholar
Vogel, C. and Marcotte, E.M. (2012). Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227–232.10.1038/nrg3185Search in Google Scholar
White, N.M.A., Youssef, Y.M., Fendler, A., Stephan, C., Jung, K., and Yousef, G.M. (2012). The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biol. Chem. 393, 379–389.10.1515/hsz-2011-0246Search in Google Scholar
Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184–204.Search in Google Scholar
Yousef, G.M., Borgoño, C.A., White, N.M.A., Robb, J.-D., Michael, I.P., Oikonomopoulou, K., Khan, S., and Diamandis, E.P. (2004). In silico analysis of the human kallikrein gene 6. Tumour Biol. 25, 282–289.10.1159/000081393Search in Google Scholar
Yousef, G.M., Obiezu, C.V, Luo, L.-Y., Magklara, A., Borgoño, C.A., Kishi, T., Memari, N., Michael, I.P., Sidiropoulos, M., Kurlender, L., et al. (2005a). Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem. 39, 11–79.10.1016/S0065-2423(04)39002-5Search in Google Scholar
Yousef, G.M., White, N.M.A., Michael, I.P., Cho, J.C.-K., Robb, J.D., Kurlender, L., Khan, S., and Diamandis, E.P. (2005b). Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker. Tumour Biol. 26, 227–235.10.1159/000087377Search in Google Scholar PubMed
©2014 by De Gruyter
